Plasma EVs for FTD
Purpose
To gain knowledge on the molecular composition of brain cell-derived extracellular vesicles in frontotemporal dementia (FTD) patients and develop a biomarker readout that will allow for patient subgrouping at early stages of the disease.
Who can participate
Cohort 1 (FTD)
- Meet probable diagnosis of FTD
- Capacity to give full informed consent in writing or electronically, and have read and signed the informed consent forms (ICFs) based on site clinician’s determination.
- Able to perform study activities
- Age of 18 and above
Cohort 2 (Healthy Control)
- Healthy and of similar age and living in a similar environment as a subject enrolled in Cohort 1
- Age of 18 and above
Visits
This study requires a one time blood draw of ~40 ml.
